Organization
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
5 clinical trials
2 abstracts
Abstract
Surufatinib monotherapy or combined with vinorelbine as a late-line therapy in patients with refractory advanced non–small cell lung cancer (NSCLC).Org: Affiliated Cancer Hospital & Institute of Guangzhou Medical University,
Clinical trial
A Multicenter Prospective Randomized Controlled Clinical Trial of Hyperthermic Intravesical Chemotherapy After Transurethral Resection of Bladder Tumors in Patients With Non-Muscle-Invasive Bladder CancerStatus: Not yet recruiting, Estimated PCD: 2026-03-31
Clinical trial
Clinical Effect Of Application Of Jeksung Combined With Anti-radiation Spray In Patients Radiotherapy-Induced Oral Mucositis Of Local Advanced Head And Neck TumorsStatus: Completed, Estimated PCD: 2022-08-31
Clinical trial
The Effects of Subanesthetic S-ketamine on Postoperative Delirium and Cognitive Function in the Elderly Undergoing Non-cardiac Thoracic Surgery: a Protocol for Randomized, Double-blinded, placebo-and Positive-controlled, Non-inferiority TrialStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
A Phase II, Single-arm, Two-cohorts, Open-label, Single Center Study of Surufatinib or Surufatinib Combined With Vinorelbine as Third-line and Posterior Line Treatment in Patients With Non-Small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Tisleilizumab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma: a Phase 2 TrialStatus: Not yet recruiting, Estimated PCD: 2024-05-01
Abstract
Nab-paclitaxel plus cisplatin versus docetaxel plus cisplatin and 5-FU induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: A multicenter parallel controlled phase III trial.Org: Sun Yat-sen University Cancer Center Gansu Hospital, The 5th Affiliated Hospital of Sun Yat-sen University, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Department of Nasopharyngeal Carcinoma, The First People's Hao Cheng Hospital of Chenzhou, Southern Medical University, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China,